Product Information
SINGULAIR 5 MG TABLET CHEW is a brand product labeled by Organon LLC, priced at $9.2741 per EA under NDC 78206017301. Its NADAC has been published 124 times since May 22, 2024.
FDA first approved this application on Feb 20, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the montelukast sodium market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 mg/1
Manufacturer
Organon LLCNDC
78206017301
Classification
Brand
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
MONTELUKAST SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA020830FDA Approved
2/20/1998
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for SINGULAIR 5 MG TABLET CHEW has been published 124 times since May 22, 2024, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.2741 per EA |
|---|---|
| All-time high | $9.2741 (Sep 30, 2026) |
| All-time low | $8.4099 (Jun 19, 2024) |
| 52-week high | $9.2741 |
| 52-week low | $8.8325 |
| Median price | $8.8325 |
| Average price | $8.8667 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
montelukast sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Leukotriene Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SINGULAIR 5 MG TABLET CHEW?
The current National Average Drug Acquisition Cost (NADAC) for SINGULAIR 5 MG TABLET CHEW, manufactured by Organon LLC, is $9.2741 per EA (NDC 78206017301), effective Sep 30, 2026.
How has the price of SINGULAIR 5 MG TABLET CHEW changed over time?
Over the history we have for it, the NADAC for SINGULAIR 5 MG TABLET CHEW has risen 9.8%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for SINGULAIR 5 MG TABLET CHEW?
Since May 22, 2024, the NADAC for SINGULAIR 5 MG TABLET CHEW has ranged from a low of $8.4099 (Jun 19, 2024) to a high of $9.2741 (Sep 30, 2026), with a median of $8.8325 per EA.
Are there cheaper alternatives to SINGULAIR 5 MG TABLET CHEW?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MONTELUKAST SOD 5 MG TAB CHEW, is $0.0704 per EA — about 99% below SINGULAIR 5 MG TABLET CHEW.
Who manufactures SINGULAIR 5 MG TABLET CHEW?
SINGULAIR 5 MG TABLET CHEW (NDC 78206017301) is labeled by Organon LLC, and CMS classifies it as a brand product.